Prodotto aggiunto correttamente al carrello.

discount label
H-CCLCLTVFL-OH
Visualizzare in 3D

Biosynth logo

H-CCLCLTVFL-OH

Rif. 3D-PP42861

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-CCLCLTVFL-OH
Sinonimi:
  • NH2-Cys-Cys-Leu-Cys-Leu-Thr-Val-Phe-Leu-OH
Descrizione:

Peptide H-CCLCLTVFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CCLCLTVFL-OH include the following: in vivo and in vitro Anti-Tumor Efficiency by Tumor-Specific CD8+ CTL Induced with Tumor Associated Peptide Y Chu , Q HE - Chinese Journal of Cancer Biotherapy, 1996 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/portal/resource/pt/wpr-581746 Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte X Cao, X Huang, DW Ju, W Zhang, H Hamada - Cancer Gene , 2000 - nature.comhttps://www.nature.com/articles/7700114 Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors W Chen, H Qin, B Chesebro, MA Cheever - Journal of virology, 1996 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.70.11.7773-7782.1996 Flow-Microfluorometric Monitoring of VEEI Vivo, CD Oligoclonal - J Immunol, 1998 - researchgate.nethttps://www.researchgate.net/profile/Giovanni-Biasi-2/publication/13762307_Flow-Microfluorometric_Monitoring_of_Oligoclonal_CD8_T_Cell_Responses_to_an_Immunodominant_Moloney_Leukemia_Virus-Encoded_Epitope_In_Vivo/links/0c96052234e88a7705000000/Flow-Microfluorometric-Monitoring-of-Oligoclonal-CD8-T-Cell-Responses-to-an-Immunodominant-Moloney-Leukemia-Virus-Encoded-Epitope-In-Vivo.pdf MicroRNA-150 modulates intracellular Ca2+ levels in naaca¯ve CD8+ T cells by targeting TMEM20 TD Kim , HR Jung, SH Seo, SC Oh , Y Ban , X Tan - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-02697-x Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants T van Hall , EZ Wolpert, P van Veelen, S Laban - Nature medicine, 2006 - nature.comhttps://www.nature.com/articles/nm1381 Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28 T van Hall , A Sijts , M Camps, R Offringa - The Journal of , 2000 - rupress.orghttps://rupress.org/jem/article-abstract/192/4/483/25927 Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation T Toubai, Y Sun , G Luker , J Liu - Blood, The Journal , 2013 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/121/20/4231/116519 CD8+ T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor SR Jackson, MM Berrien-Elliott , JM Meyer - Immunological , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/08820139.2012.751397 Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor S Tahara-Hanaoka , K Shibuya , H Kai, A Miyamoto - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/107/4/1491/133712 Identification of a gag-encoded cytotoxic T-lymphcyte epitope from FBL3 leukemia virus-induced tumors Q Huilian, C Wei, C Yongliang - Zhongguo Mian yi xue za , 1997 - europepmc.orghttps://europepmc.org/article/cba/308126 Modification of One Epitope-Flanking Amino Acid Allows for the Induction of Friend Retrovirus-Specific CD8+ T Cells by Adenovirus-Based Immunization P Gödel, S Windmann, KK Dietze, U Dittmer - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01607-12 Hierarchal Utilization of Different T-Cell Receptor Vbeta Gene Segments in the CD8+-T-Cell Response to an Immunodominant Moloney Leukemia Virus-Encoded P Brawand, JC Cerottini, HR MacDonald - Journal of virology, 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.11.9161-9169.1999 Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo P Brawand, G Biasi, C Horvath, JC Cerottini - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/4/1659/924 Transgenic expression of Ly49A on T cells impairs a specific antitumor response P Brawand, FA Lemonnier, HR MacDonald - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/4/1871/69723 Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells MM Berrien-Elliott , J Yuan , LE Swier, SR Jackson - Cancer immunology , 2015 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/3/2/116/467709 Generation and expression of high affinity, tumor antigen-specific mouse and human T cell receptors to genetically modify CD8 (+) T cells for adoptive ML Dossett - 2006 - search.proquest.comhttps://search.proquest.com/openview/e15a6c0fb38ba9554ef38793b6bb4bcb/1?pq-origsite=gscholar&cbl=18750&diss=y Therapy with cultured T cells: principles revisited MA Cheever, W Chen - Immunological reviews, 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.1997.tb00982.x Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope LC Heukamp, T van Hall , F Ossendorp - Journal of , 2002 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2002/01000/effective_immunotherapy_of_cancer_in.5.aspx tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide J van Bergen, M Camps, R Offringa, CJM Melief - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/22/6427/506896 DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire J Rice, ML Dossett, C aca–hlen, SL Buchan - European journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200838213 Diverse Immunomodulatory Effects of Individual IFNalpha Subtypes on Virus-Specific CD8+ T Cell Responses J Dickow, S Francois, RL Kaiserling - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.02255/full Overlapping epitopes of Friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones H Uenishi, N Iwanami , K Kuribayashi, H Tamamura - Immunology letters, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247898000200 Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses G Schlecht-Louf , M Renard - Proceedings of the , 2010 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0913122107 Dissecting the immune response to Moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach G Milan, A Zambon, M Cavinato, P Zanovello - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.3.2280-2287.1999 Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors F Ossendorp , E Mengede, M Camps, R Filius - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/187/5/693/7454 Comparative evaluation of the vaccine efficacies of three adenovirus-based vector types in the Friend retrovirus infection model CP Hrycak, S Windmann, W Bayer - Journal of Virology, 2019 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01155-19 in vivo and in vitro Anti-Tumor Efficiency by Tumor-Specific CD8+ CTL Induced with Tumor Associated Peptide CHU Yiwei , HE Qiuzao - Chinese Journal of Cancer , 1996 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/gim/resource/ru/wpr-581746 Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires CC Oliveira, B Querido, M Sluijter - European journal of , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201141836 A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance A Facchinetti, SD Santa, S Mezzalira - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/9/5398/72500

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP42861 H-CCLCLTVFL-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".